nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP3A4—bone cancer	0.905	1	CbGaD
Ipratropium bromide—Dysphonia—Doxorubicin—bone cancer	0.000715	0.00752	CcSEcCtD
Ipratropium bromide—Inflammation—Methotrexate—bone cancer	0.0007	0.00737	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Cisplatin—bone cancer	0.000679	0.00714	CcSEcCtD
Ipratropium bromide—Stomatitis—Cisplatin—bone cancer	0.000675	0.0071	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Cisplatin—bone cancer	0.000673	0.00708	CcSEcCtD
Ipratropium bromide—Ulcer—Epirubicin—bone cancer	0.000672	0.00707	CcSEcCtD
Ipratropium bromide—Cardiovascular disorder—Doxorubicin—bone cancer	0.000669	0.00704	CcSEcCtD
Ipratropium bromide—Inflammation—Epirubicin—bone cancer	0.000655	0.00689	CcSEcCtD
Ipratropium bromide—Ulcer—Doxorubicin—bone cancer	0.000622	0.00654	CcSEcCtD
Ipratropium bromide—Salivary hypersecretion—Epirubicin—bone cancer	0.000617	0.00649	CcSEcCtD
Ipratropium bromide—Influenza like illness—Epirubicin—bone cancer	0.000617	0.00649	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Cisplatin—bone cancer	0.000614	0.00646	CcSEcCtD
Ipratropium bromide—Urethral disorder—Cisplatin—bone cancer	0.000609	0.00641	CcSEcCtD
Ipratropium bromide—Inflammation—Doxorubicin—bone cancer	0.000606	0.00638	CcSEcCtD
Ipratropium bromide—Visual impairment—Cisplatin—bone cancer	0.000599	0.0063	CcSEcCtD
Ipratropium bromide—Eye disorder—Cisplatin—bone cancer	0.000581	0.00611	CcSEcCtD
Ipratropium bromide—Tinnitus—Cisplatin—bone cancer	0.00058	0.0061	CcSEcCtD
Ipratropium bromide—Flushing—Cisplatin—bone cancer	0.000577	0.00607	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Cisplatin—bone cancer	0.000577	0.00607	CcSEcCtD
Ipratropium bromide—Salivary hypersecretion—Doxorubicin—bone cancer	0.000571	0.00601	CcSEcCtD
Ipratropium bromide—Influenza like illness—Doxorubicin—bone cancer	0.000571	0.00601	CcSEcCtD
Ipratropium bromide—Immune system disorder—Cisplatin—bone cancer	0.000562	0.00591	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Cisplatin—bone cancer	0.00056	0.00589	CcSEcCtD
Ipratropium bromide—Abnormal vision—Epirubicin—bone cancer	0.000554	0.00583	CcSEcCtD
Ipratropium bromide—Flatulence—Cisplatin—bone cancer	0.000533	0.00561	CcSEcCtD
Ipratropium bromide—Abnormal vision—Doxorubicin—bone cancer	0.000513	0.0054	CcSEcCtD
Ipratropium bromide—Eye pain—Epirubicin—bone cancer	0.000511	0.00538	CcSEcCtD
Ipratropium bromide—Vision blurred—Cisplatin—bone cancer	0.00051	0.00536	CcSEcCtD
Ipratropium bromide—Tremor—Cisplatin—bone cancer	0.000507	0.00533	CcSEcCtD
Ipratropium bromide—Eye pain—Doxorubicin—bone cancer	0.000473	0.00497	CcSEcCtD
Ipratropium bromide—Myalgia—Cisplatin—bone cancer	0.000461	0.00485	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000458	0.00481	CcSEcCtD
Ipratropium bromide—Oedema—Cisplatin—bone cancer	0.000442	0.00464	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Cisplatin—bone cancer	0.000442	0.00464	CcSEcCtD
Ipratropium bromide—Infection—Cisplatin—bone cancer	0.000439	0.00461	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Cisplatin—bone cancer	0.000433	0.00456	CcSEcCtD
Ipratropium bromide—Tachycardia—Cisplatin—bone cancer	0.000431	0.00453	CcSEcCtD
Ipratropium bromide—Skin disorder—Cisplatin—bone cancer	0.000429	0.00451	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Cisplatin—bone cancer	0.000427	0.00449	CcSEcCtD
Ipratropium bromide—Asthma—Methotrexate—bone cancer	0.000426	0.00448	CcSEcCtD
Ipratropium bromide—Hypotension—Cisplatin—bone cancer	0.000413	0.00434	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Methotrexate—bone cancer	0.000409	0.0043	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000402	0.00423	CcSEcCtD
Ipratropium bromide—Asthma—Epirubicin—bone cancer	0.000399	0.00419	CcSEcCtD
Ipratropium bromide—Dysphagia—Epirubicin—bone cancer	0.000399	0.00419	CcSEcCtD
Ipratropium bromide—Influenza—Epirubicin—bone cancer	0.000399	0.00419	CcSEcCtD
Ipratropium bromide—Dysuria—Methotrexate—bone cancer	0.000399	0.00419	CcSEcCtD
Ipratropium bromide—Paraesthesia—Cisplatin—bone cancer	0.000397	0.00417	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Methotrexate—bone cancer	0.000396	0.00417	CcSEcCtD
Ipratropium bromide—Dyspnoea—Cisplatin—bone cancer	0.000394	0.00414	CcSEcCtD
Ipratropium bromide—Bronchitis—Epirubicin—bone cancer	0.000384	0.00403	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Cisplatin—bone cancer	0.000381	0.00401	CcSEcCtD
Ipratropium bromide—Pain—Cisplatin—bone cancer	0.000378	0.00397	CcSEcCtD
Ipratropium bromide—Dysuria—Epirubicin—bone cancer	0.000373	0.00392	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Epirubicin—bone cancer	0.000371	0.0039	CcSEcCtD
Ipratropium bromide—Stomatitis—Methotrexate—bone cancer	0.00037	0.0039	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Methotrexate—bone cancer	0.000369	0.00388	CcSEcCtD
Ipratropium bromide—Influenza—Doxorubicin—bone cancer	0.000369	0.00388	CcSEcCtD
Ipratropium bromide—Dysphagia—Doxorubicin—bone cancer	0.000369	0.00388	CcSEcCtD
Ipratropium bromide—Asthma—Doxorubicin—bone cancer	0.000369	0.00388	CcSEcCtD
Ipratropium bromide—Pollakiuria—Epirubicin—bone cancer	0.000368	0.00387	CcSEcCtD
Ipratropium bromide—Sweating—Methotrexate—bone cancer	0.000364	0.00383	CcSEcCtD
Ipratropium bromide—Epistaxis—Methotrexate—bone cancer	0.000358	0.00377	CcSEcCtD
Ipratropium bromide—Bronchitis—Doxorubicin—bone cancer	0.000355	0.00373	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Epirubicin—bone cancer	0.000349	0.00367	CcSEcCtD
Ipratropium bromide—Stomatitis—Epirubicin—bone cancer	0.000347	0.00365	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Epirubicin—bone cancer	0.000346	0.00364	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Epirubicin—bone cancer	0.000346	0.00364	CcSEcCtD
Ipratropium bromide—Dysuria—Doxorubicin—bone cancer	0.000345	0.00363	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000343	0.00361	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methotrexate—bone cancer	0.000343	0.00361	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methotrexate—bone cancer	0.000341	0.00359	CcSEcCtD
Ipratropium bromide—Sweating—Epirubicin—bone cancer	0.000341	0.00359	CcSEcCtD
Ipratropium bromide—Pollakiuria—Doxorubicin—bone cancer	0.000341	0.00359	CcSEcCtD
Ipratropium bromide—Pharyngitis—Methotrexate—bone cancer	0.000339	0.00356	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Methotrexate—bone cancer	0.000337	0.00354	CcSEcCtD
Ipratropium bromide—Epistaxis—Epirubicin—bone cancer	0.000335	0.00353	CcSEcCtD
Ipratropium bromide—Urethral disorder—Methotrexate—bone cancer	0.000334	0.00352	CcSEcCtD
Ipratropium bromide—Sinusitis—Epirubicin—bone cancer	0.000334	0.00351	CcSEcCtD
Ipratropium bromide—Visual impairment—Methotrexate—bone cancer	0.000329	0.00346	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Cisplatin—bone cancer	0.000325	0.00342	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Doxorubicin—bone cancer	0.000323	0.00339	CcSEcCtD
Ipratropium bromide—Haemoglobin—Epirubicin—bone cancer	0.000321	0.00337	CcSEcCtD
Ipratropium bromide—Stomatitis—Doxorubicin—bone cancer	0.000321	0.00337	CcSEcCtD
Ipratropium bromide—Rhinitis—Epirubicin—bone cancer	0.00032	0.00337	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Doxorubicin—bone cancer	0.00032	0.00336	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Doxorubicin—bone cancer	0.00032	0.00336	CcSEcCtD
Ipratropium bromide—Haemorrhage—Epirubicin—bone cancer	0.000319	0.00336	CcSEcCtD
Ipratropium bromide—Eye disorder—Methotrexate—bone cancer	0.000319	0.00335	CcSEcCtD
Ipratropium bromide—Tinnitus—Methotrexate—bone cancer	0.000318	0.00334	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Epirubicin—bone cancer	0.000318	0.00334	CcSEcCtD
Ipratropium bromide—Asthenia—Cisplatin—bone cancer	0.000317	0.00333	CcSEcCtD
Ipratropium bromide—Pharyngitis—Epirubicin—bone cancer	0.000317	0.00333	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methotrexate—bone cancer	0.000317	0.00333	CcSEcCtD
Ipratropium bromide—Sweating—Doxorubicin—bone cancer	0.000315	0.00332	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Epirubicin—bone cancer	0.000315	0.00332	CcSEcCtD
Ipratropium bromide—Urethral disorder—Epirubicin—bone cancer	0.000313	0.00329	CcSEcCtD
Ipratropium bromide—Epistaxis—Doxorubicin—bone cancer	0.00031	0.00326	CcSEcCtD
Ipratropium bromide—Sinusitis—Doxorubicin—bone cancer	0.000309	0.00325	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methotrexate—bone cancer	0.000308	0.00324	CcSEcCtD
Ipratropium bromide—Visual impairment—Epirubicin—bone cancer	0.000308	0.00324	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methotrexate—bone cancer	0.000307	0.00323	CcSEcCtD
Ipratropium bromide—Diarrhoea—Cisplatin—bone cancer	0.000302	0.00318	CcSEcCtD
Ipratropium bromide—Eye disorder—Epirubicin—bone cancer	0.000298	0.00314	CcSEcCtD
Ipratropium bromide—Tinnitus—Epirubicin—bone cancer	0.000298	0.00313	CcSEcCtD
Ipratropium bromide—Haemoglobin—Doxorubicin—bone cancer	0.000297	0.00312	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Epirubicin—bone cancer	0.000296	0.00312	CcSEcCtD
Ipratropium bromide—Flushing—Epirubicin—bone cancer	0.000296	0.00312	CcSEcCtD
Ipratropium bromide—Rhinitis—Doxorubicin—bone cancer	0.000296	0.00311	CcSEcCtD
Ipratropium bromide—Haemorrhage—Doxorubicin—bone cancer	0.000295	0.00311	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Doxorubicin—bone cancer	0.000294	0.00309	CcSEcCtD
Ipratropium bromide—Pharyngitis—Doxorubicin—bone cancer	0.000293	0.00308	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Doxorubicin—bone cancer	0.000292	0.00307	CcSEcCtD
Ipratropium bromide—Dysgeusia—Methotrexate—bone cancer	0.000291	0.00306	CcSEcCtD
Ipratropium bromide—Urethral disorder—Doxorubicin—bone cancer	0.00029	0.00305	CcSEcCtD
Ipratropium bromide—Immune system disorder—Epirubicin—bone cancer	0.000288	0.00303	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Epirubicin—bone cancer	0.000288	0.00303	CcSEcCtD
Ipratropium bromide—Back pain—Methotrexate—bone cancer	0.000287	0.00302	CcSEcCtD
Ipratropium bromide—Visual impairment—Doxorubicin—bone cancer	0.000285	0.00299	CcSEcCtD
Ipratropium bromide—Vomiting—Cisplatin—bone cancer	0.000281	0.00295	CcSEcCtD
Ipratropium bromide—Vision blurred—Methotrexate—bone cancer	0.00028	0.00294	CcSEcCtD
Ipratropium bromide—Rash—Cisplatin—bone cancer	0.000278	0.00293	CcSEcCtD
Ipratropium bromide—Dermatitis—Cisplatin—bone cancer	0.000278	0.00293	CcSEcCtD
Ipratropium bromide—Eye disorder—Doxorubicin—bone cancer	0.000276	0.0029	CcSEcCtD
Ipratropium bromide—Tinnitus—Doxorubicin—bone cancer	0.000275	0.0029	CcSEcCtD
Ipratropium bromide—Flushing—Doxorubicin—bone cancer	0.000274	0.00288	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Doxorubicin—bone cancer	0.000274	0.00288	CcSEcCtD
Ipratropium bromide—Flatulence—Epirubicin—bone cancer	0.000274	0.00288	CcSEcCtD
Ipratropium bromide—Tension—Epirubicin—bone cancer	0.000273	0.00287	CcSEcCtD
Ipratropium bromide—Dysgeusia—Epirubicin—bone cancer	0.000272	0.00286	CcSEcCtD
Ipratropium bromide—Nervousness—Epirubicin—bone cancer	0.00027	0.00284	CcSEcCtD
Ipratropium bromide—Back pain—Epirubicin—bone cancer	0.000269	0.00283	CcSEcCtD
Ipratropium bromide—Immune system disorder—Doxorubicin—bone cancer	0.000267	0.00281	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Doxorubicin—bone cancer	0.000266	0.0028	CcSEcCtD
Ipratropium bromide—Nausea—Cisplatin—bone cancer	0.000262	0.00276	CcSEcCtD
Ipratropium bromide—Vision blurred—Epirubicin—bone cancer	0.000262	0.00275	CcSEcCtD
Ipratropium bromide—Cough—Methotrexate—bone cancer	0.000259	0.00273	CcSEcCtD
Ipratropium bromide—Flatulence—Doxorubicin—bone cancer	0.000253	0.00266	CcSEcCtD
Ipratropium bromide—Myalgia—Methotrexate—bone cancer	0.000253	0.00266	CcSEcCtD
Ipratropium bromide—Chest pain—Methotrexate—bone cancer	0.000253	0.00266	CcSEcCtD
Ipratropium bromide—Tension—Doxorubicin—bone cancer	0.000252	0.00265	CcSEcCtD
Ipratropium bromide—Dysgeusia—Doxorubicin—bone cancer	0.000252	0.00265	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000251	0.00264	CcSEcCtD
Ipratropium bromide—Nervousness—Doxorubicin—bone cancer	0.00025	0.00263	CcSEcCtD
Ipratropium bromide—Back pain—Doxorubicin—bone cancer	0.000249	0.00262	CcSEcCtD
Ipratropium bromide—Palpitations—Epirubicin—bone cancer	0.000246	0.00258	CcSEcCtD
Ipratropium bromide—Cough—Epirubicin—bone cancer	0.000243	0.00255	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methotrexate—bone cancer	0.000242	0.00255	CcSEcCtD
Ipratropium bromide—Vision blurred—Doxorubicin—bone cancer	0.000242	0.00255	CcSEcCtD
Ipratropium bromide—Infection—Methotrexate—bone cancer	0.000241	0.00253	CcSEcCtD
Ipratropium bromide—Hypertension—Epirubicin—bone cancer	0.00024	0.00252	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methotrexate—bone cancer	0.000238	0.0025	CcSEcCtD
Ipratropium bromide—Myalgia—Epirubicin—bone cancer	0.000237	0.00249	CcSEcCtD
Ipratropium bromide—Chest pain—Epirubicin—bone cancer	0.000237	0.00249	CcSEcCtD
Ipratropium bromide—Skin disorder—Methotrexate—bone cancer	0.000235	0.00248	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000235	0.00247	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methotrexate—bone cancer	0.000234	0.00246	CcSEcCtD
Ipratropium bromide—Dry mouth—Epirubicin—bone cancer	0.000231	0.00243	CcSEcCtD
Ipratropium bromide—Palpitations—Doxorubicin—bone cancer	0.000227	0.00239	CcSEcCtD
Ipratropium bromide—Oedema—Epirubicin—bone cancer	0.000227	0.00239	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Epirubicin—bone cancer	0.000227	0.00239	CcSEcCtD
Ipratropium bromide—Hypotension—Methotrexate—bone cancer	0.000226	0.00238	CcSEcCtD
Ipratropium bromide—Infection—Epirubicin—bone cancer	0.000225	0.00237	CcSEcCtD
Ipratropium bromide—Cough—Doxorubicin—bone cancer	0.000224	0.00236	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Epirubicin—bone cancer	0.000222	0.00234	CcSEcCtD
Ipratropium bromide—Hypertension—Doxorubicin—bone cancer	0.000222	0.00233	CcSEcCtD
Ipratropium bromide—Tachycardia—Epirubicin—bone cancer	0.000221	0.00233	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000221	0.00232	CcSEcCtD
Ipratropium bromide—Skin disorder—Epirubicin—bone cancer	0.00022	0.00232	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Epirubicin—bone cancer	0.000219	0.00231	CcSEcCtD
Ipratropium bromide—Insomnia—Methotrexate—bone cancer	0.000219	0.00231	CcSEcCtD
Ipratropium bromide—Chest pain—Doxorubicin—bone cancer	0.000219	0.0023	CcSEcCtD
Ipratropium bromide—Myalgia—Doxorubicin—bone cancer	0.000219	0.0023	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methotrexate—bone cancer	0.000218	0.00229	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000217	0.00229	CcSEcCtD
Ipratropium bromide—Dyspnoea—Methotrexate—bone cancer	0.000216	0.00227	CcSEcCtD
Ipratropium bromide—Somnolence—Methotrexate—bone cancer	0.000215	0.00227	CcSEcCtD
Ipratropium bromide—Dry mouth—Doxorubicin—bone cancer	0.000214	0.00225	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methotrexate—bone cancer	0.000213	0.00224	CcSEcCtD
Ipratropium bromide—Hypotension—Epirubicin—bone cancer	0.000212	0.00223	CcSEcCtD
Ipratropium bromide—Oedema—Doxorubicin—bone cancer	0.00021	0.00221	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Doxorubicin—bone cancer	0.00021	0.00221	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Methotrexate—bone cancer	0.000209	0.0022	CcSEcCtD
Ipratropium bromide—Fatigue—Methotrexate—bone cancer	0.000209	0.0022	CcSEcCtD
Ipratropium bromide—Infection—Doxorubicin—bone cancer	0.000208	0.00219	CcSEcCtD
Ipratropium bromide—Pain—Methotrexate—bone cancer	0.000207	0.00218	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000207	0.00217	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Doxorubicin—bone cancer	0.000206	0.00216	CcSEcCtD
Ipratropium bromide—Insomnia—Epirubicin—bone cancer	0.000205	0.00216	CcSEcCtD
Ipratropium bromide—Tachycardia—Doxorubicin—bone cancer	0.000205	0.00215	CcSEcCtD
Ipratropium bromide—Skin disorder—Doxorubicin—bone cancer	0.000204	0.00214	CcSEcCtD
Ipratropium bromide—Paraesthesia—Epirubicin—bone cancer	0.000204	0.00214	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Doxorubicin—bone cancer	0.000203	0.00213	CcSEcCtD
Ipratropium bromide—Dyspnoea—Epirubicin—bone cancer	0.000202	0.00213	CcSEcCtD
Ipratropium bromide—Somnolence—Epirubicin—bone cancer	0.000202	0.00212	CcSEcCtD
Ipratropium bromide—Dyspepsia—Epirubicin—bone cancer	0.0002	0.0021	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methotrexate—bone cancer	0.000198	0.00208	CcSEcCtD
Ipratropium bromide—Hypotension—Doxorubicin—bone cancer	0.000196	0.00206	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Epirubicin—bone cancer	0.000196	0.00206	CcSEcCtD
Ipratropium bromide—Fatigue—Epirubicin—bone cancer	0.000196	0.00206	CcSEcCtD
Ipratropium bromide—Pain—Epirubicin—bone cancer	0.000194	0.00204	CcSEcCtD
Ipratropium bromide—Constipation—Epirubicin—bone cancer	0.000194	0.00204	CcSEcCtD
Ipratropium bromide—Urticaria—Methotrexate—bone cancer	0.000193	0.00202	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methotrexate—bone cancer	0.000192	0.00201	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000191	0.00201	CcSEcCtD
Ipratropium bromide—Insomnia—Doxorubicin—bone cancer	0.00019	0.002	CcSEcCtD
Ipratropium bromide—Paraesthesia—Doxorubicin—bone cancer	0.000188	0.00198	CcSEcCtD
Ipratropium bromide—Dyspnoea—Doxorubicin—bone cancer	0.000187	0.00197	CcSEcCtD
Ipratropium bromide—Somnolence—Doxorubicin—bone cancer	0.000187	0.00196	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Epirubicin—bone cancer	0.000185	0.00195	CcSEcCtD
Ipratropium bromide—Dyspepsia—Doxorubicin—bone cancer	0.000185	0.00194	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000181	0.00191	CcSEcCtD
Ipratropium bromide—Fatigue—Doxorubicin—bone cancer	0.000181	0.0019	CcSEcCtD
Ipratropium bromide—Urticaria—Epirubicin—bone cancer	0.00018	0.00189	CcSEcCtD
Ipratropium bromide—Constipation—Doxorubicin—bone cancer	0.000179	0.00189	CcSEcCtD
Ipratropium bromide—Pain—Doxorubicin—bone cancer	0.000179	0.00189	CcSEcCtD
Ipratropium bromide—Abdominal pain—Epirubicin—bone cancer	0.000179	0.00189	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methotrexate—bone cancer	0.000179	0.00188	CcSEcCtD
Ipratropium bromide—Asthenia—Methotrexate—bone cancer	0.000174	0.00183	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Doxorubicin—bone cancer	0.000172	0.0018	CcSEcCtD
Ipratropium bromide—Pruritus—Methotrexate—bone cancer	0.000171	0.0018	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Epirubicin—bone cancer	0.000167	0.00176	CcSEcCtD
Ipratropium bromide—Urticaria—Doxorubicin—bone cancer	0.000167	0.00175	CcSEcCtD
Ipratropium bromide—Abdominal pain—Doxorubicin—bone cancer	0.000166	0.00174	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methotrexate—bone cancer	0.000166	0.00174	CcSEcCtD
Ipratropium bromide—Asthenia—Epirubicin—bone cancer	0.000163	0.00171	CcSEcCtD
Ipratropium bromide—Pruritus—Epirubicin—bone cancer	0.00016	0.00169	CcSEcCtD
Ipratropium bromide—Dizziness—Methotrexate—bone cancer	0.00016	0.00169	CcSEcCtD
Ipratropium bromide—Diarrhoea—Epirubicin—bone cancer	0.000155	0.00163	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Doxorubicin—bone cancer	0.000155	0.00163	CcSEcCtD
Ipratropium bromide—Vomiting—Methotrexate—bone cancer	0.000154	0.00162	CcSEcCtD
Ipratropium bromide—Rash—Methotrexate—bone cancer	0.000153	0.00161	CcSEcCtD
Ipratropium bromide—Dermatitis—Methotrexate—bone cancer	0.000153	0.00161	CcSEcCtD
Ipratropium bromide—Headache—Methotrexate—bone cancer	0.000152	0.0016	CcSEcCtD
Ipratropium bromide—Asthenia—Doxorubicin—bone cancer	0.000151	0.00158	CcSEcCtD
Ipratropium bromide—Dizziness—Epirubicin—bone cancer	0.00015	0.00158	CcSEcCtD
Ipratropium bromide—Pruritus—Doxorubicin—bone cancer	0.000148	0.00156	CcSEcCtD
Ipratropium bromide—Vomiting—Epirubicin—bone cancer	0.000144	0.00152	CcSEcCtD
Ipratropium bromide—Nausea—Methotrexate—bone cancer	0.000144	0.00151	CcSEcCtD
Ipratropium bromide—Diarrhoea—Doxorubicin—bone cancer	0.000144	0.00151	CcSEcCtD
Ipratropium bromide—Rash—Epirubicin—bone cancer	0.000143	0.0015	CcSEcCtD
Ipratropium bromide—Dermatitis—Epirubicin—bone cancer	0.000143	0.0015	CcSEcCtD
Ipratropium bromide—Headache—Epirubicin—bone cancer	0.000142	0.00149	CcSEcCtD
Ipratropium bromide—Dizziness—Doxorubicin—bone cancer	0.000139	0.00146	CcSEcCtD
Ipratropium bromide—Nausea—Epirubicin—bone cancer	0.000135	0.00142	CcSEcCtD
Ipratropium bromide—Vomiting—Doxorubicin—bone cancer	0.000133	0.0014	CcSEcCtD
Ipratropium bromide—Rash—Doxorubicin—bone cancer	0.000132	0.00139	CcSEcCtD
Ipratropium bromide—Dermatitis—Doxorubicin—bone cancer	0.000132	0.00139	CcSEcCtD
Ipratropium bromide—Headache—Doxorubicin—bone cancer	0.000131	0.00138	CcSEcCtD
Ipratropium bromide—Nausea—Doxorubicin—bone cancer	0.000125	0.00131	CcSEcCtD
